MODIVCARE ALERT: Bragar Eagel & Squire, P.C. is Investigating ModivCare, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against ModivCare, Inc. due to a class action complaint alleging breaches of fiduciary duties by the board of directors during a specified class period [1] Summary by Relevant Sections Class Action Allegations - The class action claims that ModivCare made misleading statements regarding its contracts' ability to stabilize cash flow, leading to significant stock price declines as the truth about the company's business emerged [2] - On September 16, 2024, ModivCare revised its 2024 Adjusted EBITDA guidance from a range of $185-$195 million to $170-$180 million, primarily due to pricing accommodations in the NEMT segment to retain key customer relationships [2] - Following this announcement, ModivCare's stock price dropped by $1.40, nearly 10%, from $14.12 per share on September 15, 2024, to $12.72 per share on September 16, 2024, with unusually high trading volume [2] Contact Information - Long-term stockholders of ModivCare who have information or questions regarding the claims can contact Bragar Eagel & Squire, P.C. via email or telephone, with no cost or obligation [3] About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in various complex litigations across state and federal courts [4]